Marker Therapeutics (MRKR) Other Gross PP&E Adjustments (2018 - 2023)
Historic Other Gross PP&E Adjustments for Marker Therapeutics (MRKR) over the last 6 years, with Q2 2023 value amounting to -$525000.0.
- Marker Therapeutics' Other Gross PP&E Adjustments fell 10669.52% to -$525000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was -$525000.0, marking a year-over-year decrease of 10442.3%. This contributed to the annual value of $11.6 million for FY2022, which is 839516.55% up from last year.
- According to the latest figures from Q2 2023, Marker Therapeutics' Other Gross PP&E Adjustments is -$525000.0, which was down 10669.52% from $11.9 million recorded in Q1 2023.
- In the past 5 years, Marker Therapeutics' Other Gross PP&E Adjustments registered a high of $11.9 million during Q1 2023, and its lowest value of -$14.4 million during Q4 2020.
- Its 5-year average for Other Gross PP&E Adjustments is $645689.1, with a median of -$244568.0 in 2019.
- As far as peak fluctuations go, Marker Therapeutics' Other Gross PP&E Adjustments crashed by 5475258.65% in 2020, and later soared by 839516.55% in 2022.
- Marker Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$26174.0 in 2019, then tumbled by 54752.59% to -$14.4 million in 2020, then surged by 100.95% to $136539.0 in 2021, then soared by 8395.17% to $11.6 million in 2022, then tumbled by 104.53% to -$525000.0 in 2023.
- Its last three reported values are -$525000.0 in Q2 2023, $11.9 million for Q1 2023, and $11.6 million during Q4 2022.